GlassScriptPhysician profile
Krystal Bell
NPI 1619323557
$1,582.31
in general payments reported to CMS, 2019-2025
22 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.46 · 2020: $51.02 · 2021: $416 · 2022: $115 · 2023: $228 · 2024: $426 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.05 |
| Education | $278.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.66 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $367.41 | 2023-2025 | Veozah |
| Organon LLC | $96.56 | 2021-2025 | Nexplanon |
| Shield Therapeutics INC | $91.87 | 2024-2025 | |
| Biogen, INC. | $89.46 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $87.26 | 2025 | Pico 7 |
| Exeltis, USA INC. | $69.23 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $59.10 | 2020-2022 | |
| Amgen INC. | $48.09 | 2019-2021 | |
| Myriad Women'S Health, INC. | $34.68 | 2023 | Myrisk |
| Boston Scientific Corporation | $27.95 | 2023 | Wavewriter Alpha Prime 16 |
| Avanos Medical | $27.90 | 2021 | |
| Mayne Pharma Commercial LLC | $26.93 | 2023 | |
| Medtronic, INC. | $26.61 | 2023 | V-Loc 180 |
| Therapeuticsmd, INC. | $26.41 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.19 | 2020 | |
| Ethicon US, LLC | $18.80 | 2021 | |
| Pfizer INC. | $18.62 | 2024 | |
| Acessa Health INC. | $17.64 | 2021 | |
| Astellas Pharma Global Development | $16.66 | 2025 | Veozah |
| Molnlycke Health Care US, LLC | $16.39 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Agile Therapeutics, INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystal Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.